Status of surgical treatment of biliary tract cancer

Digestive Surgery

Volumn 24, Issue 2, 2007, Pages 131-136

  Ishihara, Shin ^a,b,j   Miyakawa, Shuichi ^a,b   Takada, Tadahiro ^c   Takasaki, Ken ^d   Nimura, Yuji ^e   Tanaka, Masao ^f   Miyazaki, Masaru ^g   Nagakawa, Takukazu ^h   Kayahara, Masato ⁱ   Horiguchi, Akihiko ^a,b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b Registration Secretariat   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g CHIBA UNIVERSITY   (Japan)

^h Fukuno Hospital   (Japan)

ⁱ KANAZAWA UNIVERSITY   (Japan)

^j NONE   (Japan)

more..

Author keywords

Bile duct carcinoma, hilar, middle, distal; Biliary surgery, 5 year survival; Biliary tract carcinoma; Disease stage; Gallbladder carcinoma; Papilla of Vater carcinoma

Indexed keywords

AUTONOMIC NERVE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLECYSTECTOMY; DISSECTION; HUMAN; JAPAN; LIVER LOBECTOMY; LIVER RESECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NERVE SURGERY; PANCREATICODUODENECTOMY; PYLORUS; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR SURGERY; VATER PAPILLA CARCINOMA;

AMPULLA OF VATER; BILE DUCT NEOPLASMS; BILIARY TRACT NEOPLASMS; GALLBLADDER NEOPLASMS; HUMANS; JAPAN;

EID: 34249052235     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101901     Document Type: Review

References (24)

1. Japanese Society of Biliary Surgery: Classification of Biliary Tract Carcinoma, second English edition. Tokyo, Kanehara, 2004.
2. Mizumoto R, Suzuki H: Surgical anatomy of hepatic hilum with special reference to the caudate lobe. World J Surg 1988;12:2-10.
3. Nimura Y, Hayakawa N, Kamiya J, et al: Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;14:535-544.
4. Miyazaki M, Ito H, Nakagawa K, et al: Parenchyma-preserving hepatectomy in surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999;189:575-583.
5. Kosuge T, Yamamoto J, Shimada K, et al: Improved surgery results for hilar cholangiocarcinoma. Ann Surg 1999;230:663-671.
6. Todoroki T, Kawamoto T, Koike N, et al: Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000;87:306-313.
7. Tabata M, Kawarada Y, Yokoi H, et al: Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000;7:148-154.
8. Seyama Y, Kubota K, Sano K, et al: Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003;238:73-83.
9. Kawasaki S, Imamura H, Kobayashi A, et al: Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003;238:84-92.
10. Kondo S, Hirano S, Ambo Y, et al: Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004;240:95-101.
11. Nagino S, Kamiya J, Nishio H, et al: Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006;243:364-372.
12. Yamaguchi K, Chijiiwa K, Saiki S, et al: Carcinoma of extrahepatic bile duct: mode of spread and its prognostic implications. Hepatogastroenterology 1997;44:1256-1261.
13. Kayahara M, Nagakawa T, Ohta T, et al: Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 1999;229:76-83.
14. Suzuki M, Unno M, Oikawa M, et al: Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan-experience of a single institute. Hepatogastroenterology 2000;47:650-657.
15. Sasaki R, Takahashi M, Funato O, et al: Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 2001;129:677-683.
16. Yoshida T, Matsumoto T, Sasaki A, et al: Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 2002;137:69-73.
17. Sakamoto Y, Kosuge T, Shimada K, et al: Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radical margins. Surgery 2005;137:396-402.
18. Ogura Y, Mizumoto R, Isaji S, et al: Radical options for carcinoma of gallbladder: present status in Japan. World J Surg 1991;15:337-343.
19. Nagakawa T, Kayahara M, Ikeda S, et al: Biliary tract cancer treatment: results from the biliary tract cancer statistics registry in Japan. J Hepatobiliary Pancreat Surg 2002;9:569-575.
20. Kawarada Y, Takahashi K, Tabata M, et al: Surgical treatment for carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 1993;1:8-13.
21. Nakao A, Harada A, Nonami T, et al: Prognosis of cancer of the duodenal papilla of Vater in relation to clinicopathological tumor extension. Hepatogastroenterology 1994;41:650-657.
22. Shirai Y, Tsukada K, Ohtani T, et al: Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996;61:190-194.
23. Kayahara M, Nagakawa T, Ohta T, et al: Surgical strategy for carcinoma of the papilla of Vater on basis of lymphatic spread and mode recurrence. Surgery 1997;121:611-617.
24. Tanaka S, Hirohashi K, Tanaka H, et al: Prognostic factors in patient with carcinoma of the papilla of Vater. Hepatogastroenterology 2002;49:1116-1119.